IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 6179 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded336    
    Comments [Add]    

Recommend this journal


Year : 1997  |  Volume : 29  |  Issue : 1  |  Page : 3-10

An update on pharmacological prospectives for prevention and development of cataract

Correspondence Address:
S K Gupta

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Cataract is one of the leading causes of visual disability, often leading to blindness. The situation can be remedied surgically by extirpation of the cataractous lens. Various pharmacological strategies have been proposed for prevention and treatment of cataract. The present article deals with the wholearea from aldose reductase inhibitors (ARI) through aspirin, ibuprofen, bendazac, glutathione boosters, antiglycating agents, vitamins and various drugs from indigenous sources. Recently various substances with dietse chemical structures and properties have been claimed to possess anti-cataract potential in experimental models. Some of them have been evaluated in clinical trials but failed in final stages due to adverse side effects. Till day no anti-cataract drug is approved for the medical therapy of cataract anywhere in the world. However, agents with un-proven efficacy are available in some developing countries. It is probable that some agents will come up soon and will be useful in delaying the onset and progression of cataract formation in humans.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow